Baicalein inhibits KB oral cancer cells by inducing apoptosis via modulation of ROS. Current Medical and Drug Research, [S. l.], v. 4, n. 1, p. 1–4, 2020. Disponível em: https://cmdrj.com/index.php/cmdrj/article/view/53. Acesso em: 21 oct. 2026.